Get the Stockscreener App
3.42
3.32%
0.11
After Hours:
3.38
-0.04
-1.17%
Aquestive Therapeutics Inc Stock (AQST) Forecast
The Aquestive Therapeutics Inc (AQST) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.2213, representing a +23.43% increase from the current price of $3.42. The highest analyst price target is $5.3575, and the lowest is $3.0852.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AQST Price Target
Average 5.189
(+51.73% Upside)
Is Aquestive Therapeutics Inc (AQST) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 63.70 | Neutral |
| STOCH(9,6) | 71.06 | Neutral |
| STOCHRSI(14) | 59.57 | Neutral |
| MACD(12,26) | 0.2257 | Buy |
| ADX(14) | 29.03 | Buy |
| William %R | -27.43 | Neutral |
| CCI(14) | 32.82 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.379
Buy
|
3.3047
Buy
|
| MA20 |
2.935
Buy
|
3.1021
Buy
|
| MA50 |
2.7768
Buy
|
2.9277
Buy
|
| MA100 |
2.8759
Buy
|
3.0329
Buy
|
| MA200 |
3.6727
Sell
|
3.2334
Buy
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, AQST could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 1 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on AQST, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 63.7 indicates that AQST is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 71.06 indicates that AQST is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 59.57 indicates that AQST is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.03 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 32.82 indicates that AQST is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term AQST price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Aquestive Therapeutics Inc financial reports and earnings history, Aquestive Therapeutics Inc (AQST) stock could reach $2.2175 by 2030, $2.5071 by 2040 and $3.9173 by 2050. See the projected annual prices until 2050 of the Aquestive Therapeutics Inc stock below:
- Aquestive Therapeutics Inc (AQST) is expected to reach an average price of $0.2127 in 2035, with a high prediction of $0.704 and a low estimate of $0.6027. This indicates an $-93.78% rise from the last recorded price of $3.42.
- Aquestive Therapeutics Inc (AQST) stock is projected to chart a bullish course in 2040, with an average price target of $2.3503, representing an $-31.28% surge from its current level. The forecast ranges from a conservative $2.4759 to a sky-high $2.5071.
- Our analysts predict Aquestive Therapeutics Inc (AQST) to jump 20.26% by 2045, soaring from $3.9873 to an average price of $4.1128, potentially reaching $3.9683. While $3.9873 is the low estimate, the potential upside is significant.
- Aquestive Therapeutics Inc (AQST) stock is expected to climb by 2050, reaching an average of $4.0291, a $17.81% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.9173 and $3.9678, respectively, highlighting the market's uncertainty.
Aquestive Therapeutics Inc Stock (AQST) Year by Year Forecast
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2025
Aquestive Therapeutics Inc Stock (AQST) is expected to reach an average price of $4.0006 in 2025, with a high prediction of $7.9462 and a low estimate of $0.055. This indicates an +16.98% rise from the last recorded price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $3.855 | $3.0852 | $5.3575 | +12.72% |
| August, 2025 | $2.7525 | $2.6625 | $4.3769 | -19.52% |
| September, 2025 | $4.76 | $2.4543 | $4.80 | +39.18% |
| October, 2025 | $5.7093 | $4.7818 | $7.4237 | +66.94% |
| November, 2025 | $3.3418 | $2.8868 | $7.9462 | -2.29% |
| December, 2025 | $3.3362 | $2.8687 | $4.0343 | -2.45% |
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2026
The predicted value for Aquestive Therapeutics Inc (AQST) in 2026 is set at an average of $4.1231. Estimates vary from a peak of $6.5712 to a trough of $1.675, indicating an +20.56% surge from the present price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.5537 | $3.1481 | $5.9018 | +62.39% |
| February, 2026 | $5.4312 | $4.5312 | $6.5712 | +58.81% |
| March, 2026 | $3.8487 | $3.5187 | $5.4431 | +12.54% |
| April, 2026 | $4.1781 | $3.6028 | $5.5229 | +22.17% |
| May, 2026 | $3.7056 | $2.4318 | $4.2278 | +8.35% |
| June, 2026 | $3.2231 | $2.5093 | $3.9693 | -5.76% |
| July, 2026 | $1.9825 | $1.7225 | $3.285 | -42.03% |
| August, 2026 | $2.79 | $1.8962 | $2.90 | -18.42% |
| September, 2026 | $2.2093 | $1.9193 | $3.1537 | -35.40% |
| October, 2026 | $2.3168 | $1.675 | $2.4967 | -32.26% |
| November, 2026 | $3.1643 | $2.1487 | $3.2643 | -7.48% |
| December, 2026 | $2.9437 | $2.5976 | $3.3862 | -13.93% |
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Aquestive Therapeutics Inc (AQST) is $2.5165, with a high forecast of $5.0124 and a low forecast of $0.0206. This indicates an -26.42% decrease from the last price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.9182 | $2.2674 | $3.2812 | -14.67% |
| February, 2027 | $4.5787 | $2.9141 | $4.9887 | +33.88% |
| March, 2027 | $4.3181 | $3.1762 | $5.0124 | +26.26% |
| April, 2027 | $2.3156 | $2.1056 | $4.8699 | -32.29% |
| May, 2027 | $1.2231 | $1.1093 | $2.2775 | -64.24% |
| June, 2027 | $1.5424 | $0.6588 | $1.8324 | -54.90% |
| July, 2027 | $1.2599 | $0.9762 | $1.6343 | -63.16% |
| August, 2027 | $0.6574 | $0.5674 | $1.3318 | -80.78% |
| September, 2027 | $0.3032 | $0.0206 | $0.6938 | -91.13% |
| October, 2027 | $0.6196 | $0.3413 | $0.4257 | -81.88% |
| November, 2027 | $0.561 | $0.6738 | $0.6661 | -83.60% |
| December, 2027 | $0.4212 | $0.4288 | $0.4712 | -87.68% |
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2028
In 2028, Aquestive Therapeutics Inc (AQST) is projected to reach an average price of $0.7362, with a high projection of $1.4674 and a low estimate of $0.00493. This indicates an -78.47% fall from the last price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.00868 | $0.00493 | $0.4607 | -99.75% |
| February, 2028 | $0.1238 | $0.0694 | $0.2024 | -96.38% |
| March, 2028 | $0.4145 | $0.242 | $0.3845 | -87.88% |
| April, 2028 | $0.3573 | $0.3288 | $0.3737 | -89.55% |
| May, 2028 | $0.3376 | $0.3582 | $0.3275 | -90.13% |
| June, 2028 | $0.3363 | $0.3466 | $0.3458 | -90.17% |
| July, 2028 | $0.3826 | $0.3863 | $0.3496 | -88.81% |
| August, 2028 | $0.4495 | $0.4769 | $0.4351 | -86.86% |
| September, 2028 | $0.0657 | $0.2257 | $0.4064 | -98.08% |
| October, 2028 | $0.8118 | $0.012 | $1.1717 | -76.26% |
| November, 2028 | $1.0412 | $0.4737 | $1.4674 | -69.56% |
| December, 2028 | $0.4387 | $0.1187 | $1.1249 | -87.17% |
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2029
The 2029 price forecast for Aquestive Therapeutics Inc Stock (AQST) is $2.5856 on average, with a high prediction of $5.1011 and a low estimate of $0.0701. This represents an -24.40% decrease from the previous price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.988 | $0.3243 | $1.068 | -71.11% |
| February, 2029 | $0.5955 | $0.4337 | $1.0899 | -82.59% |
| March, 2029 | $0.433 | $0.2812 | $0.5974 | -87.34% |
| April, 2029 | $0.3605 | $0.0701 | $0.5976 | -89.46% |
| May, 2029 | $0.5099 | $0.1843 | $0.6424 | -85.09% |
| June, 2029 | $1.2274 | $0.3818 | $1.3174 | -64.11% |
| July, 2029 | $0.8649 | $0.683 | $1.5093 | -74.71% |
| August, 2029 | $1.2443 | $0.7968 | $1.6605 | -63.62% |
| September, 2029 | $1.4318 | $1.2561 | $1.808 | -58.14% |
| October, 2029 | $3.2511 | $1.4936 | $5.1011 | -4.94% |
| November, 2029 | $2.9836 | $2.5986 | $3.4186 | -12.76% |
| December, 2029 | $1.70 | $1.19 | $3.3805 | -50.29% |
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2030
Aquestive Therapeutics Inc Stock (AQST) is expected to reach an average price of $3.4494 in 2030, with a high forecast of $6.7937 and a low forecast of $0.105. This signifies an +0.86% surge from the last price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.8387 | $0.355 | $2.2175 | -75.48% |
| February, 2030 | $1.0397 | $0.5462 | $1.6725 | -69.60% |
| March, 2030 | $0.00126 | $0.145 | $1.0775 | -99.96% |
| April, 2030 | $0.5637 | $0.2262 | $1.045 | -83.52% |
| May, 2030 | $0.0325 | $0.105 | $0.7675 | -99.05% |
| June, 2030 | $0.0675 | $0.1263 | $0.4237 | -98.03% |
| July, 2030 | $3.2162 | $0.1912 | $3.9862 | -5.96% |
| August, 2030 | $2.2112 | $1.8975 | $6.7937 | -35.34% |
| September, 2030 | $3.3862 | $2.1287 | $3.7761 | -0.99% |
| October, 2030 | $1.215 | $0.5875 | $2.54 | -64.47% |
| November, 2030 | $1.45 | $0.1126 | $1.3387 | -57.60% |
| December, 2030 | $1.285 | $1.0188 | $1.1063 | -62.43% |
2.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):